Vitamin D during pregnancy may boost children’s bone health
Taking extra vitamin D during pregnancy may improve the bone health of children, according to a new study.
Related Articles
Evolving Treatments and Advances in HER2-Positive Breast Cancer
Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the potential for improved outcomes.
Bridging the gap between clinical services and research – Evidence-Based Nursing blog
Bridging the gap between clinical services and research: Implementing a trust-wide research link initiative Nicola Manning @nicmanning2 Deputy Director of Research Nursing. University Hospitals Bristol…
The Power of Knowledge and Staying Informed in Breast Cancer Care
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
ACCC Learning: Optimizing Lung Cancer Care Through Patient Navigation
You must have an ACCC account in order to register for this webinar. To start, click the green “Register” button in the upper right corner…
CJON Writing Mentorship Program
The Clinical Journal of Oncology Nursing (CJON) Writing Mentorship Program is looking for experienc
What Patients With Breast Cancer Need to Know About Itovebi
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according to Dr. Kevin Kalinsky.
Cardiff urged to drop ‘alarming’ nursing school closure proposal | Nursing Times
Read about the RCN’s demands for Cardiff University to abandon plans to scrap its nursing courses in the coming years.
A Heaven-Sent Sign About My Brother’s Lymphoma
Cancer runs in the family, and after I’d dealt with two breast cancers, my brother came down with lymphoma.
NMC defines advanced practice for first time | Nursing Times
Find out more about the Nursing and Midwifery Council’s new principles and definition of advanced practice.
Golidocitinib Plus PD-1 Antibodies Being Explored in Lung Cancer Subset
Findings on golidocitinib with PD-1 antibodies for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will be presented this month.